Publication vom 20.08.2020
Do new generations of active pharmaceuticals for human use require an adaption of the environmental risk assessment?, Part I: Literature review
… classes (oncology, neurology, cardiology). The proposed assessment includes additional test methods, groups of organisms and alternative endpoints. The …
